FIELD: medicine, dermatology, pharmacy. SUBSTANCE: invention relates to pharmaceutical composition exhibiting efficiency against cutaneous diseases. Pharmaceutical composition comprises macrolide compound, for example, tricyclic compound FK506 or its pharmaceutically acceptable salt, promoter of dissolving/absorption, pharmaceutical base, combining agent and thickening agent. Said composition satisfies to requirements of stability, absorption kinetics and low irritation potential. EFFECT: valuable properties of composition. 6 cl, 4 tbl, 6 ex
| Title |
Year |
Author |
Number |
| MEDICINAL COMPOSITIONS |
1997 |
- Khata Takekhisa
- Tokunaga Judzi
- Simodzo Fumio
- Kimura Sumikhisa
- Khirose Takeo
- Ueda Satosi
|
RU2197226C2 |
| PHARMACEUTICAL COMPOSITION SHOWING IMMUNOSUPPRESSIVE AND ANTIMICROBIAL ACTIVITIES |
1991 |
- Sotoo Asakura[Jp]
- Jasuto Kojama[Jp]
- Eukhej Kieta[Jp]
- Kieko Akasi[Jp]
- Akira Kagajama[Jp]
- Esio Murakami[Jp]
- Tosiomi Nakate[Jp]
|
RU2079304C1 |
| IMMUNOSUPPRESSIVE COMPOSITION AND A METHOD OF ITS SYNTHESIS |
1991 |
- Sotoo Asakura[Jp]
- Mitijo Fukae[Jp]
- Sigeo Nakanisi[Jp]
- Jasuto Kojama[Jp]
- Joukhei Kijota[Jp]
|
RU2084222C1 |
| AMIDES OF ACIDS, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
2000 |
|
RU2208608C2 |
| SUSTAINED-RELEASE PREPARATIONS |
1999 |
- Jamasita Kazunari
- Khasimoto Eidzi
- Nomura Jukikhiro
- Simodzo Fumio
- Tamura Sigeki
- Khirose Takeo
- Ueda Satosi
- Saitokh Takasi
- Ibuki Rinta
- Ideno Tosio
|
RU2214244C2 |
| ACID AMIDES, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
2000 |
|
RU2211215C2 |
| PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF TACHYKININ EFFECT |
1993 |
- Masaaki Matsuo
- Dajdzhiro Khagivara
- Khirosi Mijake
|
RU2119922C1 |
| 1,2,3,4-TETRAHYDROPYRAZOLO-[5,1-C]-(1,2,4)-TRIAZINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION INHIBITING PRODUCING AN INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR, METHOD OF PROPHYLACTIC OR THERAPEUTIC TREATMENT OF PATIENTS WITH DISEASES MEDIATED BY INTERLEUKIN AND TUMOR NECROSIS FACTOR |
1994 |
- Esio Kavai
- Khitosi Jamazaki
- Khirokazu Tanaka
- Teruo Oku
|
RU2124517C1 |
| PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF DISEASE TREATMENT INTERMEDIARY AGENT OF THAT IS TACHIKININ |
1991 |
- Masaaki Matsuo[Jp]
- Dajdziro Khagivara[Jp]
- Khirosi Mijake[Jp]
|
RU2073683C1 |
| DERIVATIVES OF PYRAZOLO-[1,5-A]-PYRIDINE OR THEIR PHARMACEUTICAL ACCEPTABLE SALTS AND METHOD OF THEIR SYNTHESIS |
1992 |
- Euiti Siokava[Jp]
- Atsusi Akakhane[Jp]
- Khirokhito Katajama[Jp]
- Takafumi Mitsunaga[Jp]
|
RU2069662C1 |
